Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Gallo

Showing results (81-90 of 135) with videos related to

Pageof 14
Sort By:
Life Sciences|March 9, 2002
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatinSabrina Giacomelli, Daniela Gallo, Patrizia Apollonio, et al.
Cancer Letters|August 17, 2002
Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumorsDaniela Gallo, Gabriella Ferrandina, Sabrina Giacomelli, et al.
Ophthalmology and Therapy|January 29, 2026
Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker QuantificationNicolò Bartolomeo, Konstantinos Kitsos Kalyvianakis, Yannic Pannatier Schuetz, et al.
Biochemical Pharmacology|August 1, 2009
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanomaIlaria De Stefano, Giuseppina Raspaglio, Gian Franco Zannoni, et al.
Menopause (New York, N.Y.)|September 8, 2005
Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profileDaniela Gallo, Gian Franco Zannoni, Patrizia Apollonio, et al.
Scientific Reports|October 31, 2018
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6Marta De Donato, Benedetta Righino, Flavia Filippetti, et al.
Molecular Pharmacology|June 20, 2003
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2020
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancerMarta De Donato, Gabriele Babini, Simona Mozzetti, et al.
Gynecologic Oncology|June 14, 2011
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancerIlaria De Stefano, Gian Franco Zannoni, Maria Grazia Prisco, et al.
Cancer Research|December 17, 2008
Molecular mechanisms of patupilone resistanceSimona Mozzetti, Raffaella Iantomasi, Ilaria De Maria, et al.
Pageof 14

Showing results (81-90 of 135) with videos related to

Sort By:
Pageof 14
Life Sciences|March 9, 2002
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatinSabrina Giacomelli, Daniela Gallo, Patrizia Apollonio, et al.
Cancer Letters|August 17, 2002
Dietary soy modulation of biochemical parameters in DMBA-induced mammary tumorsDaniela Gallo, Gabriella Ferrandina, Sabrina Giacomelli, et al.
Ophthalmology and Therapy|January 29, 2026
Early Outcomes of Intravitreal Aflibercept 8 mg in Eyes Previously Treated with Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration with AI-Based Biomarker QuantificationNicolò Bartolomeo, Konstantinos Kitsos Kalyvianakis, Yannic Pannatier Schuetz, et al.
Biochemical Pharmacology|August 1, 2009
Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanomaIlaria De Stefano, Giuseppina Raspaglio, Gian Franco Zannoni, et al.
Menopause (New York, N.Y.)|September 8, 2005
Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profileDaniela Gallo, Gian Franco Zannoni, Patrizia Apollonio, et al.
Scientific Reports|October 31, 2018
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6Marta De Donato, Benedetta Righino, Flavia Filippetti, et al.
Molecular Pharmacology|June 20, 2003
Bcl-2 down-regulation is a novel mechanism of paclitaxel resistanceCristiano Ferlini, Giuseppina Raspaglio, Simona Mozzetti, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 30, 2020
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancerMarta De Donato, Gabriele Babini, Simona Mozzetti, et al.
Gynecologic Oncology|June 14, 2011
Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancerIlaria De Stefano, Gian Franco Zannoni, Maria Grazia Prisco, et al.
Cancer Research|December 17, 2008
Molecular mechanisms of patupilone resistanceSimona Mozzetti, Raffaella Iantomasi, Ilaria De Maria, et al.
Pageof 14